CTNM
Financials
- Market Capitalization 336.55 M
- Employee 51
- Founded 2009
- CEO N/A
- Website www.contineum-tx.com
- Headquarter Delaware, United States
- FIGI BBG01M27SVP6
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3225 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 4.77 USD | +3.25% | 0.00% | +26.86% | +253.33% | 339.56 M USD | ||
| 3229 |  IMRX Immuneering Corporation - Class A Common Stock | 5.21 USD | +0.97% | +0.97% | +24.34% | +28.33% | 337.07 M USD | ||
| 3232 |  PALI Palisade Bio, Inc. - Common Stock | 1.93 USD | +2.12% | -5.85% | +14.88% | +13.53% | 335.01 M USD | ||
| 3295 |  FHTX Foghorn Therapeutics Inc. - Common Stock | 5.38 USD | -1.10% | -8.97% | +30.58% | +31.86% | 315.88 M USD |
Frequently asked questions about Contineum Therapeutics, Inc. - Common stock
What is the Contineum Therapeutics, Inc. - Common stock stock price today?
The current price of Contineum Therapeutics, Inc. - Common stock (CTNM) is 14.57. Over the past 24 hours, the stock has changed by -0.34%. Follow the CTNM chart for real-time price dynamics.
What is the stock ticker of Contineum Therapeutics, Inc. - Common stock?
Contineum Therapeutics, Inc. - Common stock trades under the ticker CTNM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Contineum Therapeutics, Inc. - Common stock stock going up?
CTNM has changed by -0.27% over the last week, +15.00% over the last month, and -4.58% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Contineum Therapeutics, Inc. - Common stock net income for the last quarter?
Contineum Therapeutics, Inc. - Common stock reported net income of -14.46 M for the last quarter. The previous quarter showed -15.16 M, which means net income changed by +4.62%.
How many employees does Contineum Therapeutics, Inc. - Common stock have?
As of the latest available data, Contineum Therapeutics, Inc. - Common stock has 51 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Contineum Therapeutics, Inc. - Common stock stock?
You can buy Contineum Therapeutics, Inc. - Common stock (CTNM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Contineum Therapeutics, Inc. - Common stock stock?
Investing in Contineum Therapeutics, Inc. - Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CTNM chart and related analysis on metatrader.com as part of your research.